Hirschsprung disease occurs in approximately 1 in 5,000 live births. The classic description of Hirschsprung disease was credited to Harald Hirschsprung in 1887. 1 This disease entity is characterized by absence of parasympathetic ganglion cells in the myenteric (Auerbach) and submucosal (Meissner) plexi of the affected colon, causing a sustained contraction of that segment. In approximately 80% of cases, the aganglionic segment involves the rectum and the sigmoid colon only, whereas in 20% of cases, the aganglionic segment involves the more proximal bowel, sometimes extending to variable lengths of the ileum.
The ganglion cells migrate to the bowel from the neural crest. Hirschsprung disease is thought to be a neurocristopathy, related to the premature arrest of the craniocaudal migration of these cells during the 5th to 12th week of gestation. Mutations in several genes have been associated with aberrant population of the fetal distal gut, including ret. 2 In human fetal models of Hirschsprung disease, the ganglion cells had not been observed in the distal gut before their appearance in the proximal gut. This has significant implications for the surgical treatment of the disease because most of the time, there are no skip lesions. Once the transition zone has been identified, the surgeon can be confident that the exact extent of the disease is known. 3 The diagnosis and extent of resection for the management of Hirschsprung disease depend on the sensitive and specific identification of ganglion cells. Despite the availability of special techniques such as acetylcholinesterase histochemical analysis and S-100 protein and neuron-specific enolase (NSE) immunohistochemical analysis, examination of serial H&E-stained sections remains the standard approach for establishing this diagnosis. However, documenting aganglionosis often is difficult on routine H&E-stained sections, acetylcholinesterase histochemical analysis is technically challenging, and S-100 and NSE staining lack sensitivity and specificity.
In Hirschsprung disease, the ret signaling pathway has a critical role. To briefly summarize, ret is a proto-oncogene with a 114 amino acid transmembrane receptor with a cadherin-like extracellular domain, a cysteine-rich region, and an intracellular tyrosine kinase domain. It is expressed in the developing central and peripheral nervous systems. Unlike in the cancer susceptibility syndromes, mutations in Hirschsprung disease are inactivating and lead to misfolding or failure to transport the protein to the cell surface, effectively resulting in half the usual dose of the functioning protein, a situation known as haploinsufficiency. Half of the wild-type ret is not sufficient for normal enteric development. 4 This loss of ret expression resulting in aganglionosis can be exploited to establish the diagnosis of Hirschsprung disease. We compared ret immunoreactivity with H&E light microscopic examination in an effort to find a sensitive and dependable marker for identifying ganglion cells.
Materials and Methods
A computer-based search was performed for cases of Hirschsprung disease in the Department of Pathology, Baystate Medical Center, Springfield, MA, from June 1990 to April 2004. We retrieved 61 formalin-fixed, paraffin-embedded tissue blocks from colonic and rectal biopsies relating to 46 patients with a clinical suspicion of Hirschsprung disease. Another 47 blocks from resection specimens from 14 patients with Hirschsprung disease also were retrieved. Other possible cases were not included owing to technical factors, including lack of sufficient tissue in the block or biopsy specimens that were too superficial or too distal. In 53 of these blocks from 34 patients (24 from biopsies and 29 from resection specimens), ganglion cells were evident on the original H&E-stained sections, whereas 55 blocks from 38 patients (37 from biopsies and 18 from resection specimens) were lacking ganglion cells on the original H&E-stained sections. The study was approved by the institutional review board of Baystate Medical Center.
The 108 blocks were sectioned (4 µm), deparaffinized, cleared, and rehydrated in graded ethanol concentrations. A commercially available ret monoclonal antibody was used at a 1:200 dilution (clone 3F8, Vector Laboratories, Burlingame, CA). Antigen retrieval was performed by microwave using BioGenex Antigen retrieval Citra solution (BioGenex, San Ramon, CA). Immunohistochemical analysis was performed on the DakoCytomation Autostainer (DakoCytomation, Santa Barbara, CA) using the Signet Acuity Polymer Horseradish Peroxidase/Diaminobenzidine Detection System (Signet Laboratories, Cambridge, MA). An adjacent section from each block was stained with H&E to minimize the block sampling variation in ganglion cell population. The ret immunohistochemical sections were compared with the adjacent H&E-stained sections for the presence of ganglion cells and with the original H&E-stained sections. The 6 blocks, which originally were stained with NSE, S-100, and synaptophysin, also were compared with the results of ret immunohistochemical analysis and H&E staining. Of the 108 blocks, 53 demonstrated ganglion cells on the original H&E-stained sections. The number of original H&E-stained levels on the 61 biopsy blocks ranged from 2 to 25, with a mean of 7.59.
Results
The ret oncoprotein was detected in the cytoplasm of ganglion cells, where intense paranuclear distribution of immunoreactivity was present. Schwann cells and nerve trunks were weakly immunoreactive, and, therefore, the hypertrophied nerve fibers in aganglionic intestinal segments did not show a conspicuous reaction. Endothelial cells and fibroblasts were nonimmunoreactive for ret.
A significant observation was the ease with which ganglion cells were identified by ret immunohistochemical analysis ❚Image 1❚. The importance of this became more obvious in superficial neonatal biopsy specimens, many of which contained small, less differentiated ganglion cells in the submucosal (Meissner) plexi ❚Image 2❚, as demonstrated in ❚Table 1❚ and ❚Table 2❚.
Comparison of Results for ret Immunohistochemical Staining and Adjacent H&E Staining
All 42 blocks with ganglion cells identified on the adjacent H&E-stained sections also were positive for ganglion cells by ret immunohistochemical analysis ❚Table 3❚ (rows 1 and 5). There were no cases in which ret immunohistochemical analysis failed to demonstrate ganglion cells that were identified on the adjacent H&E-stained sections (Table 3 , row 2).
Of 65 blocks negative for ganglion cells on the adjacent H&E-stained sections, 63 (97%) did not demonstrate ganglion cells on ret immunohistochemically stained sections (Table 3 , rows 3 and 4). However, 2 blocks that were negative for ganglion cells on the adjacent H&E-stained sections (3%) showed ganglion cells on ret immunohistochemically stained sections (Table  3 , row 6), and 1 block showed a ganglion cell that was stained with ret but was not positively identified in the adjacent H&E-stained section (Table 3 , row 7).
Comparison of Original H&E and ret Immunohistochemical Staining (With Adjacent H&E)
Original sections of 13 blocks with ganglion cells were negative for ganglion cells by ret immunohistochemical analysis and on the adjacent H&E-stained sections (Table 3 , row 3). This highlights the variation in ganglion cell populations within the paraffin blocks and is the reasoning for including an adjacent section for true comparison between results of H&E and ret oncoprotein staining in identifying ganglion cells. Two blocks demonstrated ganglion cells on ret and adjacent H&E-stained sections, although the original H&E levels were negative for ganglion cells (Table 3 , row 5), again indicating the ganglion cell population variability within the paraffin block.
Comparison of ret Immunohistochemical Stains and Other Immunohistochemical Stains Applied in the Original Diagnosis
The 6 blocks that originally were stained with NSE, S-100, and synaptophysin to aid the routine H&E examination in the identification of ganglion cells demonstrated the same results on ret staining. Of these 6 blocks, 1 was positive for ganglion cells on all stains, including the original immunohistochemical stains and the ret stain, whereas the remaining 5 blocks did not demonstrate any ganglion cells with these stains, including ret.
Discussion
Histologic examination of colorectal specimens for the presence of ganglion cells remains the standard method of evaluating patients with Hirschsprung disease and forms the basis for surgical treatment (Image 1A, Image 2A, and ❚Image 3❚). The difficulty in identifying neonatal ganglion cells by morphologic examination is well known. Fibroblasts and endothelial cells may be confused with ganglion cells. This difficulty in interpretation may result in inadequate resection of bowel segments or resection of unnecessarily long segments of bowel. Therefore, various techniques have been assessed to facilitate the determination of ganglionic or aganglionic bowel. [5] [6] [7] [8] The acetylcholinesterase histochemical stain has diagnostic value in Hirschsprung disease because it demonstrates ganglion cells and abnormal mucosal cholinergic nerve fibers. 4, [9] [10] [11] [12] [13] However, it requires frozen tissue with its associated compromise in morphologic features. Moreover, the preparations may be difficult to interpret because the histochemical procedure may produce variable results. Most laboratories perform the stain by hand. Several series also have documented false-negative [14] [15] [16] and false-positive 13, 17 staining in biopsy specimens examined for Hirschsprung disease. 18 Immunohistochemical evaluations have led to less laborintensive procedures with the widespread application of semiautomated instrumentation. S-100 antibodies have been applied to the diagnosis of Hirschsprung disease. However, S-100 does not stain ganglion cells; rather it is immunoreactive to nerve fibers-normal and hypertrophied-and the cytoplasm and nuclei of Schwann cells. This produces a contrast picture of the unmarked ganglion cells surrounded by axons and interstitial cells with intense immunoreactivity. 19 Because a negatively stained cell would be difficult to identify, some researchers have advised using S-100 protein with NSE in the same histologic specimen to enhance the visualization of ganglion cells, 18 which will stain positively with NSE along with all other intestinal neuronal elements, including Schwann cells and nerve fibers, but will not stain with S-100 protein.
The ret oncoprotein is expressed in the ganglia of normal colon and in the ganglionic colonic segments of patients with Hirschsprung disease. 20 A partial synthesis of this receptor tyrosine kinase can be shown in the ganglionic and hypoganglionic segments of patients with total disruption of the ret gene structure (frameshift mutation with stop codon in the extracellular domain) 20 or complete deletion of the ret gene. 20, 21 In these conditions, a dose effect could account for the migration arrest of the neuroblasts causing Hirschsprung +  +  2  1  3  3  0  3  0  +  +  -0  0  0  0  0  0  12  +  --2  3  3  1  0  3  34  ---8  8  2  6  3  7  1  -+  +  0  0  0  0  0  1  2 *  --+  0  0  1  1  0  0 MM, biopsy specimens containing mucosa and muscularis mucosae; MM(s), mucosa and superficial muscularis mucosae; MP, mucosa, muscularis mucosae, submucosa, and muscularis propria; MP(o), muscularis propria only; SM, mucosa, muscularis mucosae, and submucosa; SM(s), mucosa, muscularis mucosae, and superficial submucosa. * Cases in which ganglion cells were highlighted by ret immunohistochemical analysis; however, the original and the adjacent H&E-stained sections failed to reveal ganglion cells. disease. 22 Therefore, antibodies against the ret oncoprotein can be used to detect ganglion cells. Immunohistochemical detection of ganglion cells by using ret is technically routine, less labor-intensive than histochemical procedures, and reproducible, yielding slides that are easily interpreted (Images 1B and 2B). The ganglion cells are intensely immunoreactive in a clean background, resulting in a desirable high signal/noise ratio. Suture material stained nonspecifically in a biopsy specimen. However, the morphologic features were easily identified as a foreign body rather than a ganglion cell. Significantly, the immature ganglion cells of neonates, which may be confused with endothelial cells, macrophages, fibroblasts, or Schwann cells by routine H&E staining, were intensely immunoreactive with ret oncoprotein (Image 2B).
This study demonstrated that ret immunoreactivity has comparable specificity but slightly higher sensitivity than routine H&E staining in the identification of ganglion cells in biopsy and resection specimens from patients in whom there is a clinical suspicion of Hirschsprung disease. Ganglion cells are more readily identified by ret immunoreactivity than by routine morphologic examination. The immunohistochemical procedure is routine and may be performed on an automated immunohistochemical platform.
This study did not address the intraoperative assessment of biopsy or resection specimens for ganglion cells by frozen section. However, surgical resection of affected bowel commonly is preceded by an endoscopic biopsy specimen consisting of at least the submucosa. These may be multiple biopsy specimens, which subsequently are evaluated by routine formalin-fixed, paraffin-embedded processing.
Immunohistochemical analysis using ret should be considered as the standard adjunctive procedure in the evaluation of biopsy or resection specimens for ganglion cells in patients suspected of having or diagnosed with Hirschsprung disease. Although an exact protocol for the evaluation of such biopsy specimens has not been established based on sensitivity and specificity, our results suggest that a combination of routine H&E-stained sections with intervening ret immunohistochemical preparations is an optimal method for evaluating bowel specimens for Hirschsprung disease. Perhaps an alternative, more cost-effective method is to approach the tissue submitted for evaluation in 2 steps. The first step would include evaluation of H&E-stained sections while saving unstained intervening levels for future ret immunohistochemical analysis. If the initial examination identifies ganglion cells or deems a biopsy specimen insufficient, the unstained slides are not subjected to immunohistochemical evaluation. However, if the specimen is adequate and no ganglion cells are found by H&E examination, the intervening unstained slides are evaluated for ret oncoprotein by immunohistochemical analysis.
❚Image 3❚ Ganglion cells are immunoreactive for ret oncoprotein. However, peripheral nerve elements are nonimmunoreactive, as are endothelial cells and fibroblasts, leading to readily identifiable ganglion cells (×50).
